OSTERWEIS CAPITAL MANAGEMENT INC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1007524
SAN FRANCISCO, CA
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,101,175
New position
Shares Held
50,315
first reported quarter
Ownership
0.036%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#140
of 497 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026OSTERWEIS CAPITAL MANAGEMENT INC holds $28,588,525 across 6 Biotechnology names. ARWR ranks #3 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCEL |
Vericel Corp
|
398,365 | $17,723,258 | |
| 2 | COGT |
Cogent Biosciences, Inc.
|
172,085 | $6,659,689 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
50,315 | $4,101,175 | |
| 4 | SMMT |
Summit Therapeutics Inc.
|
5,000 | $72,850 | |
| 5 | SPRY |
ARS Pharmaceuticals, Inc.
|
2,637 | $21,122 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21 | $10,431 |
All Filings in ARWR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,101,175 | 50,315 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||